{"public_id":"cl_1cee88df1fd04bacfd3f625341e8fba9","status":"active","superseded_by_public_id":null,"corpus_id":21754500,"text":"CD133+ cells isolated from the 22Rv1 prostate cancer cell line show high clonogenicity, tumorigenicity, sphere-forming capacity, and the ability to serially reinitiate transplantable tumors in NOD-SCID mice.","confidence":0.98,"paper":{"corpus_id":21754500,"title":"Acquisition of tumorigenic potential and therapeutic resistance in CD133+ subpopulation of prostate cancer cells exhibiting stem-cell like characteristics.","url":"https://sah.borca.ai/papers/21754500"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.98,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_419f3a05b9f4d285e216a4e183adc9b7","name":"NOD-SCID mice","description":"Immunodeficient mice used as hosts for transplantable tumor assays.","types":["animal model"],"url":"https://sah.borca.ai/concepts/co_419f3a05b9f4d285e216a4e183adc9b7"},{"public_id":"co_c07e90256a5cfabcc04acc8c3102dda5","name":"CD133+ cells","description":"A subpopulation of prostate cancer cells that expresses the CD133/Prominin-1 surface marker.","types":["cell population"],"url":"https://sah.borca.ai/concepts/co_c07e90256a5cfabcc04acc8c3102dda5"},{"public_id":"co_fdaab7ae0472181ff0ac380edb7687e7","name":"22Rv1 prostate cancer cell line","description":"A human prostate cancer cell line used as the source of isolated CD133+ cells.","types":["cell line"],"url":"https://sah.borca.ai/concepts/co_fdaab7ae0472181ff0ac380edb7687e7"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_1cee88df1fd04bacfd3f625341e8fba9"}